Norris Medicines Limited (BOM:524414)

Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	187	134	168	136	105	350
Market Cap Growth	16.73%	-20.44%	23.38%	30.14%	-70.10%	437.69%
Enterprise Value	402	348	383	351	319	550
Last Close Price	18.70	13.35	16.78	13.60	10.45	34.95

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PS Ratio	2.46	1.64	2.88	2.41	1.25	3.70
PB Ratio	-1.23	-0.88	-1.13	-1.00	-0.84	-3.27
P/FCF Ratio	32.46	23.17	34.17	80.65	8.94	-
P/OCF Ratio	31.93	22.79	32.90	80.11	8.71	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	5.29	4.27	6.59	6.23	3.82	5.83
EV/EBITDA Ratio	76.64	51.21	110.56	-	34.52	-
EV/EBIT Ratio	-	184.88	-	-	108.08	-
EV/FCF Ratio	69.80	60.33	78.09	208.24	27.30	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Debt / EBITDA Ratio	41.04	31.73	62.23	-	23.13	-
Debt / FCF Ratio	-	37.38	43.95	127.63	18.30	-
Net Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Net Debt / EBITDA Ratio	41.00	31.70	62.11	-120.43	23.11	-334.03
Net Debt / FCF Ratio	-	37.34	43.87	127.41	18.28	-19.78
Asset Turnover	-	0.61	0.42	0.40	0.60	0.56
Inventory Turnover	-	1.09	0.83	0.72	1.25	1.48
Quick Ratio	-	0.13	0.14	0.12	0.14	0.16
Current Ratio	-	0.61	0.63	0.67	0.64	0.63
Return on Assets (ROA)	-	0.88%	-0.85%	-3.36%	1.32%	-2.65%
Return on Capital Employed (ROCE)	-	5.60%	-5.20%	-15.10%	4.90%	-9.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 24, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-1.96%	-2.10%	-7.37%	-8.72%	-16.74%	-9.34%
FCF Yield	3.08%	4.32%	2.93%	1.24%	11.19%	-3.05%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 24, 2026

Data Sources Report a data error